As the global economy mends, the 2021 growth of Transdermal Drug Patches will have significant change from previous year. According to our latest study, the global Transdermal Drug Patches market size is USD million in 2022 from USD 6513.2 million in 2021, with a change of % between 2021 and 2022. The global Transdermal Drug Patches market size will reach USD 8243.7 million in 2028, growing at a CAGR of 3.4% over the analysis period.
The United States Transdermal Drug Patches market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transdermal Drug Patches market, reaching US$ million by the year 2028. As for the Europe Transdermal Drug Patches landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Transdermal Drug Patches players cover Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, and UCB Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Rx Channel
OTC Channel
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Patches Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Transdermal Drug Patches by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Transdermal Drug Patches by Country/Region, 2017, 2022 & 2028
2.2 Transdermal Drug Patches Segment by Type
2.2.1 Methyl Salicylate-based Patch
2.2.2 Rivastigmine Transdermal Patch
2.2.3 Fentanyl Transdermal Patch
2.2.4 Lidocaine Patch
2.2.5 Diclofenac Patch
2.2.6 Nicotine Transdermal Patch
2.2.7 Others
2.3 Transdermal Drug Patches Sales by Type
2.3.1 Global Transdermal Drug Patches Sales Market Share by Type (2017-2022)
2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2017-2022)
2.3.3 Global Transdermal Drug Patches Sale Price by Type (2017-2022)
2.4 Transdermal Drug Patches Segment by Application
2.4.1 Rx Channel
2.4.2 OTC Channel
2.5 Transdermal Drug Patches Sales by Application
2.5.1 Global Transdermal Drug Patches Sale Market Share by Application (2017-2022)
2.5.2 Global Transdermal Drug Patches Revenue and Market Share by Application (2017-2022)
2.5.3 Global Transdermal Drug Patches Sale Price by Application (2017-2022)
3 Global Transdermal Drug Patches by Company
3.1 Global Transdermal Drug Patches Breakdown Data by Company
3.1.1 Global Transdermal Drug Patches Annual Sales by Company (2020-2022)
3.1.2 Global Transdermal Drug Patches Sales Market Share by Company (2020-2022)
3.2 Global Transdermal Drug Patches Annual Revenue by Company (2020-2022)
3.2.1 Global Transdermal Drug Patches Revenue by Company (2020-2022)
3.2.2 Global Transdermal Drug Patches Revenue Market Share by Company (2020-2022)
3.3 Global Transdermal Drug Patches Sale Price by Company
3.4 Key Manufacturers Transdermal Drug Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transdermal Drug Patches Product Location Distribution
3.4.2 Players Transdermal Drug Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transdermal Drug Patches by Geographic Region
4.1 World Historic Transdermal Drug Patches Market Size by Geographic Region (2017-2022)
4.1.1 Global Transdermal Drug Patches Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Transdermal Drug Patches Annual Revenue by Geographic Region
4.2 World Historic Transdermal Drug Patches Market Size by Country/Region (2017-2022)
4.2.1 Global Transdermal Drug Patches Annual Sales by Country/Region (2017-2022)
4.2.2 Global Transdermal Drug Patches Annual Revenue by Country/Region
4.3 Americas Transdermal Drug Patches Sales Growth
4.4 APAC Transdermal Drug Patches Sales Growth
4.5 Europe Transdermal Drug Patches Sales Growth
4.6 Middle East & Africa Transdermal Drug Patches Sales Growth
5 Americas
5.1 Americas Transdermal Drug Patches Sales by Country
5.1.1 Americas Transdermal Drug Patches Sales by Country (2017-2022)
5.1.2 Americas Transdermal Drug Patches Revenue by Country (2017-2022)
5.2 Americas Transdermal Drug Patches Sales by Type
5.3 Americas Transdermal Drug Patches Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Drug Patches Sales by Region
6.1.1 APAC Transdermal Drug Patches Sales by Region (2017-2022)
6.1.2 APAC Transdermal Drug Patches Revenue by Region (2017-2022)
6.2 APAC Transdermal Drug Patches Sales by Type
6.3 APAC Transdermal Drug Patches Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transdermal Drug Patches by Country
7.1.1 Europe Transdermal Drug Patches Sales by Country (2017-2022)
7.1.2 Europe Transdermal Drug Patches Revenue by Country (2017-2022)
7.2 Europe Transdermal Drug Patches Sales by Type
7.3 Europe Transdermal Drug Patches Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Patches by Country
8.1.1 Middle East & Africa Transdermal Drug Patches Sales by Country (2017-2022)
8.1.2 Middle East & Africa Transdermal Drug Patches Revenue by Country (2017-2022)
8.2 Middle East & Africa Transdermal Drug Patches Sales by Type
8.3 Middle East & Africa Transdermal Drug Patches Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Drug Patches
10.3 Manufacturing Process Analysis of Transdermal Drug Patches
10.4 Industry Chain Structure of Transdermal Drug Patches
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transdermal Drug Patches Distributors
11.3 Transdermal Drug Patches Customer
12 World Forecast Review for Transdermal Drug Patches by Geographic Region
12.1 Global Transdermal Drug Patches Market Size Forecast by Region
12.1.1 Global Transdermal Drug Patches Forecast by Region (2023-2028)
12.1.2 Global Transdermal Drug Patches Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transdermal Drug Patches Forecast by Type
12.7 Global Transdermal Drug Patches Forecast by Application
13 Key Players Analysis
13.1 Hisamitsu Pharmaceutical
13.1.1 Hisamitsu Pharmaceutical Company Information
13.1.2 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Offered
13.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hisamitsu Pharmaceutical Main Business Overview
13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Transdermal Drug Patches Product Offered
13.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Transdermal Drug Patches Product Offered
13.3.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 UCB Pharma
13.4.1 UCB Pharma Company Information
13.4.2 UCB Pharma Transdermal Drug Patches Product Offered
13.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 UCB Pharma Main Business Overview
13.4.5 UCB Pharma Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Transdermal Drug Patches Product Offered
13.5.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Transdermal Drug Patches Product Offered
13.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Nitto Denko
13.7.1 Nitto Denko Company Information
13.7.2 Nitto Denko Transdermal Drug Patches Product Offered
13.7.3 Nitto Denko Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nitto Denko Main Business Overview
13.7.5 Nitto Denko Latest Developments
13.8 Grünenthal
13.8.1 Grünenthal Company Information
13.8.2 Grünenthal Transdermal Drug Patches Product Offered
13.8.3 Grünenthal Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Grünenthal Main Business Overview
13.8.5 Grünenthal Latest Developments
13.9 IBSA Group
13.9.1 IBSA Group Company Information
13.9.2 IBSA Group Transdermal Drug Patches Product Offered
13.9.3 IBSA Group Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 IBSA Group Main Business Overview
13.9.5 IBSA Group Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK Transdermal Drug Patches Product Offered
13.10.3 GSK Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Luye Pharma Group
13.11.1 Luye Pharma Group Company Information
13.11.2 Luye Pharma Group Transdermal Drug Patches Product Offered
13.11.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Luye Pharma Group Main Business Overview
13.11.5 Luye Pharma Group Latest Developments
13.12 Pfizer
13.12.1 Pfizer Company Information
13.12.2 Pfizer Transdermal Drug Patches Product Offered
13.12.3 Pfizer Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Pfizer Main Business Overview
13.12.5 Pfizer Latest Developments
13.13 Chattem
13.13.1 Chattem Company Information
13.13.2 Chattem Transdermal Drug Patches Product Offered
13.13.3 Chattem Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Chattem Main Business Overview
13.13.5 Chattem Latest Developments
13.14 Dr Reddy’s Laboratories
13.14.1 Dr Reddy’s Laboratories Company Information
13.14.2 Dr Reddy’s Laboratories Transdermal Drug Patches Product Offered
13.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Dr Reddy’s Laboratories Main Business Overview
13.14.5 Dr Reddy’s Laboratories Latest Developments
13.15 Bayer
13.15.1 Bayer Company Information
13.15.2 Bayer Transdermal Drug Patches Product Offered
13.15.3 Bayer Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Bayer Main Business Overview
13.15.5 Bayer Latest Developments
13.16 Mundipharma
13.16.1 Mundipharma Company Information
13.16.2 Mundipharma Transdermal Drug Patches Product Offered
13.16.3 Mundipharma Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Mundipharma Main Business Overview
13.16.5 Mundipharma Latest Developments
13.17 Endo International
13.17.1 Endo International Company Information
13.17.2 Endo International Transdermal Drug Patches Product Offered
13.17.3 Endo International Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Endo International Main Business Overview
13.17.5 Endo International Latest Developments
13.18 Beijing Tide Pharmaceutical
13.18.1 Beijing Tide Pharmaceutical Company Information
13.18.2 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Offered
13.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Beijing Tide Pharmaceutical Main Business Overview
13.18.5 Beijing Tide Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Transdermal Drug Patches Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transdermal Drug Patches Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Methyl Salicylate-based Patch
Table 4. Major Players of Rivastigmine Transdermal Patch
Table 5. Major Players of Fentanyl Transdermal Patch
Table 6. Major Players of Lidocaine Patch
Table 7. Major Players of Diclofenac Patch
Table 8. Major Players of Nicotine Transdermal Patch
Table 9. Major Players of Others
Table 10. Global Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 11. Global Transdermal Drug Patches Sales Market Share by Type (2017-2022)
Table 12. Global Transdermal Drug Patches Revenue by Type (2017-2022) & ($ million)
Table 13. Global Transdermal Drug Patches Revenue Market Share by Type (2017-2022)
Table 14. Global Transdermal Drug Patches Sale Price by Type (2017-2022) & (US$/Pc)
Table 15. Global Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 16. Global Transdermal Drug Patches Sales Market Share by Application (2017-2022)
Table 17. Global Transdermal Drug Patches Revenue by Application (2017-2022)
Table 18. Global Transdermal Drug Patches Revenue Market Share by Application (2017-2022)
Table 19. Global Transdermal Drug Patches Sale Price by Application (2017-2022) & (US$/Pc)
Table 20. Global Transdermal Drug Patches Sales by Company (2020-2022) & (M Pcs)
Table 21. Global Transdermal Drug Patches Sales Market Share by Company (2020-2022)
Table 22. Global Transdermal Drug Patches Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Transdermal Drug Patches Revenue Market Share by Company (2020-2022)
Table 24. Global Transdermal Drug Patches Sale Price by Company (2020-2022) & (US$/Pc)
Table 25. Key Manufacturers Transdermal Drug Patches Producing Area Distribution and Sales Area
Table 26. Players Transdermal Drug Patches Products Offered
Table 27. Transdermal Drug Patches Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Transdermal Drug Patches Sales by Geographic Region (2017-2022) & (M Pcs)
Table 31. Global Transdermal Drug Patches Sales Market Share Geographic Region (2017-2022)
Table 32. Global Transdermal Drug Patches Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Transdermal Drug Patches Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Transdermal Drug Patches Sales by Country/Region (2017-2022) & (M Pcs)
Table 35. Global Transdermal Drug Patches Sales Market Share by Country/Region (2017-2022)
Table 36. Global Transdermal Drug Patches Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Transdermal Drug Patches Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Transdermal Drug Patches Sales by Country (2017-2022) & (M Pcs)
Table 39. Americas Transdermal Drug Patches Sales Market Share by Country (2017-2022)
Table 40. Americas Transdermal Drug Patches Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Transdermal Drug Patches Revenue Market Share by Country (2017-2022)
Table 42. Americas Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 43. Americas Transdermal Drug Patches Sales Market Share by Type (2017-2022)
Table 44. Americas Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 45. Americas Transdermal Drug Patches Sales Market Share by Application (2017-2022)
Table 46. APAC Transdermal Drug Patches Sales by Region (2017-2022) & (M Pcs)
Table 47. APAC Transdermal Drug Patches Sales Market Share by Region (2017-2022)
Table 48. APAC Transdermal Drug Patches Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Transdermal Drug Patches Revenue Market Share by Region (2017-2022)
Table 50. APAC Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 51. APAC Transdermal Drug Patches Sales Market Share by Type (2017-2022)
Table 52. APAC Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 53. APAC Transdermal Drug Patches Sales Market Share by Application (2017-2022)
Table 54. Europe Transdermal Drug Patches Sales by Country (2017-2022) & (M Pcs)
Table 55. Europe Transdermal Drug Patches Sales Market Share by Country (2017-2022)
Table 56. Europe Transdermal Drug Patches Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Transdermal Drug Patches Revenue Market Share by Country (2017-2022)
Table 58. Europe Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 59. Europe Transdermal Drug Patches Sales Market Share by Type (2017-2022)
Table 60. Europe Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 61. Europe Transdermal Drug Patches Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Transdermal Drug Patches Sales by Country (2017-2022) & (M Pcs)
Table 63. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Transdermal Drug Patches Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 67. Middle East & Africa Transdermal Drug Patches Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 69. Middle East & Africa Transdermal Drug Patches Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Transdermal Drug Patches
Table 71. Key Market Challenges & Risks of Transdermal Drug Patches
Table 72. Key Industry Trends of Transdermal Drug Patches
Table 73. Transdermal Drug Patches Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Transdermal Drug Patches Distributors List
Table 76. Transdermal Drug Patches Customer List
Table 77. Global Transdermal Drug Patches Sales Forecast by Region (2023-2028) & (M Pcs)
Table 78. Global Transdermal Drug Patches Sales Market Forecast by Region
Table 79. Global Transdermal Drug Patches Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Transdermal Drug Patches Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Transdermal Drug Patches Sales Forecast by Country (2023-2028) & (M Pcs)
Table 82. Americas Transdermal Drug Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Transdermal Drug Patches Sales Forecast by Region (2023-2028) & (M Pcs)
Table 84. APAC Transdermal Drug Patches Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Transdermal Drug Patches Sales Forecast by Country (2023-2028) & (M Pcs)
Table 86. Europe Transdermal Drug Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Transdermal Drug Patches Sales Forecast by Country (2023-2028) & (M Pcs)
Table 88. Middle East & Africa Transdermal Drug Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Transdermal Drug Patches Sales Forecast by Type (2023-2028) & (M Pcs)
Table 90. Global Transdermal Drug Patches Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Transdermal Drug Patches Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Transdermal Drug Patches Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Transdermal Drug Patches Sales Forecast by Application (2023-2028) & (M Pcs)
Table 94. Global Transdermal Drug Patches Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Transdermal Drug Patches Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Transdermal Drug Patches Revenue Market Share Forecast by Application (2023-2028)
Table 97. Hisamitsu Pharmaceutical Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 98. Hisamitsu Pharmaceutical Transdermal Drug Patches Product Offered
Table 99. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 100. Hisamitsu Pharmaceutical Main Business
Table 101. Hisamitsu Pharmaceutical Latest Developments
Table 102. Johnson & Johnson Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson Transdermal Drug Patches Product Offered
Table 104. Johnson & Johnson Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 105. Johnson & Johnson Main Business
Table 106. Johnson & Johnson Latest Developments
Table 107. Novartis Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis Transdermal Drug Patches Product Offered
Table 109. Novartis Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 110. Novartis Main Business
Table 111. Novartis Latest Developments
Table 112. UCB Pharma Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 113. UCB Pharma Transdermal Drug Patches Product Offered
Table 114. UCB Pharma Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 115. UCB Pharma Main Business
Table 116. UCB Pharma Latest Developments
Table 117. Mylan Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 118. Mylan Transdermal Drug Patches Product Offered
Table 119. Mylan Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 120. Mylan Main Business
Table 121. Mylan Latest Developments
Table 122. Teva Pharmaceutical Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 123. Teva Pharmaceutical Transdermal Drug Patches Product Offered
Table 124. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 125. Teva Pharmaceutical Main Business
Table 126. Teva Pharmaceutical Latest Developments
Table 127. Nitto Denko Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 128. Nitto Denko Transdermal Drug Patches Product Offered
Table 129. Nitto Denko Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 130. Nitto Denko Main Business
Table 131. Nitto Denko Latest Developments
Table 132. Grünenthal Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 133. Grünenthal Transdermal Drug Patches Product Offered
Table 134. Grünenthal Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 135. Grünenthal Main Business
Table 136. Grünenthal Latest Developments
Table 137. IBSA Group Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 138. IBSA Group Transdermal Drug Patches Product Offered
Table 139. IBSA Group Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 140. IBSA Group Main Business
Table 141. IBSA Group Latest Developments
Table 142. GSK Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 143. GSK Transdermal Drug Patches Product Offered
Table 144. GSK Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 145. GSK Main Business
Table 146. GSK Latest Developments
Table 147. Luye Pharma Group Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 148. Luye Pharma Group Transdermal Drug Patches Product Offered
Table 149. Luye Pharma Group Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 150. Luye Pharma Group Main Business
Table 151. Luye Pharma Group Latest Developments
Table 152. Pfizer Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 153. Pfizer Transdermal Drug Patches Product Offered
Table 154. Pfizer Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 155. Pfizer Main Business
Table 156. Pfizer Latest Developments
Table 157. Chattem Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 158. Chattem Transdermal Drug Patches Product Offered
Table 159. Chattem Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 160. Chattem Main Business
Table 161. Chattem Latest Developments
Table 162. Dr Reddy’s Laboratories Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 163. Dr Reddy’s Laboratories Transdermal Drug Patches Product Offered
Table 164. Dr Reddy’s Laboratories Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 165. Dr Reddy’s Laboratories Main Business
Table 166. Dr Reddy’s Laboratories Latest Developments
Table 167. Bayer Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 168. Bayer Transdermal Drug Patches Product Offered
Table 169. Bayer Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 170. Bayer Main Business
Table 171. Bayer Latest Developments
Table 172. Mundipharma Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 173. Mundipharma Transdermal Drug Patches Product Offered
Table 174. Mundipharma Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 175. Mundipharma Main Business
Table 176. Mundipharma Latest Developments
Table 177. Endo International Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 178. Endo International Transdermal Drug Patches Product Offered
Table 179. Endo International Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 180. Endo International Main Business
Table 181. Endo International Latest Developments
Table 182. Beijing Tide Pharmaceutical Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 183. Beijing Tide Pharmaceutical Transdermal Drug Patches Product Offered
Table 184. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue ($ Million), Price (US$/Pc) and Gross Margin (2020-2022)
Table 185. Beijing Tide Pharmaceutical Main Business
Table 186. Beijing Tide Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Transdermal Drug Patches
Figure 2. Transdermal Drug Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transdermal Drug Patches Sales Growth Rate 2017-2028 (M Pcs)
Figure 7. Global Transdermal Drug Patches Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Transdermal Drug Patches Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Methyl Salicylate-based Patch
Figure 10. Product Picture of Rivastigmine Transdermal Patch
Figure 11. Product Picture of Fentanyl Transdermal Patch
Figure 12. Product Picture of Lidocaine Patch
Figure 13. Product Picture of Diclofenac Patch
Figure 14. Product Picture of Nicotine Transdermal Patch
Figure 15. Product Picture of Others
Figure 16. Global Transdermal Drug Patches Sales Market Share by Type in 2021
Figure 17. Global Transdermal Drug Patches Revenue Market Share by Type (2017-2022)
Figure 18. Transdermal Drug Patches Consumed in Rx Channel
Figure 19. Global Transdermal Drug Patches Market: Rx Channel (2017-2022) & (M Pcs)
Figure 20. Transdermal Drug Patches Consumed in OTC Channel
Figure 21. Global Transdermal Drug Patches Market: OTC Channel (2017-2022) & (M Pcs)
Figure 22. Global Transdermal Drug Patches Sales Market Share by Application (2017-2022)
Figure 23. Global Transdermal Drug Patches Revenue Market Share by Application in 2021
Figure 24. Transdermal Drug Patches Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Transdermal Drug Patches Revenue Market Share by Company in 2021
Figure 26. Global Transdermal Drug Patches Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Transdermal Drug Patches Revenue Market Share by Geographic Region in 2021
Figure 28. Global Transdermal Drug Patches Sales Market Share by Region (2017-2022)
Figure 29. Global Transdermal Drug Patches Revenue Market Share by Country/Region in 2021
Figure 30. Americas Transdermal Drug Patches Sales 2017-2022 (M Pcs)
Figure 31. Americas Transdermal Drug Patches Revenue 2017-2022 ($ Millions)
Figure 32. APAC Transdermal Drug Patches Sales 2017-2022 (M Pcs)
Figure 33. APAC Transdermal Drug Patches Revenue 2017-2022 ($ Millions)
Figure 34. Europe Transdermal Drug Patches Sales 2017-2022 (M Pcs)
Figure 35. Europe Transdermal Drug Patches Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Transdermal Drug Patches Sales 2017-2022 (M Pcs)
Figure 37. Middle East & Africa Transdermal Drug Patches Revenue 2017-2022 ($ Millions)
Figure 38. Americas Transdermal Drug Patches Sales Market Share by Country in 2021
Figure 39. Americas Transdermal Drug Patches Revenue Market Share by Country in 2021
Figure 40. United States Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Transdermal Drug Patches Sales Market Share by Region in 2021
Figure 45. APAC Transdermal Drug Patches Revenue Market Share by Regions in 2021
Figure 46. China Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Transdermal Drug Patches Sales Market Share by Country in 2021
Figure 53. Europe Transdermal Drug Patches Revenue Market Share by Country in 2021
Figure 54. Germany Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country in 2021
Figure 61. Egypt Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Transdermal Drug Patches Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Transdermal Drug Patches in 2021
Figure 67. Manufacturing Process Analysis of Transdermal Drug Patches
Figure 68. Industry Chain Structure of Transdermal Drug Patches
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles